الاتحاد الأوروبي - السويدية - EMA (European Medicines Agency)

astrazeneca ab - osimertinib mesilate - carcinom, non-small cell lung - andra antineoplastiska medel, protein kinas-hämmare - tagrisso as monotherapy is indicated for:- the adjuvant treatment after complete tumour resection in adult patients with stage ib-iiia non-small cell lung cancer (nsclc) whose tumours have epidermal growth factor receptor (egfr) exon 19 deletions or exon 21 (l858r) substitution mutations- the first-line treatment of adult patients nsclc with activating egfr mutations. - the treatment of adult patients with locally advanced or metastatic egfr t790m mutation-positive nsclc. tagrisso as monotherapy is indicated for:- the adjuvant treatment after complete tumour resection in adult patients with stage ib-iiia non-small cell lung cancer (nsclc) whose tumours have epidermal growth factor receptor (egfr) exon 19 deletions or exon 21 (l858r) substitution mutations. - the first-line treatment of adult patients with locally advanced or metastatic nsclc with activating egfr mutations. - the treatment of adult patients with locally advanced or metastatic egfr t790m mutation-positive nsclc.

السويد - السويدية - Läkemedelsverket (Medical Products Agency)

ge healthcare limited - krom(cr-51)edetat - injektionsvätska, lösning - 3,7 mbq/ml - bensylalkohol hjälpämne; krom(cr-51)edetat 3,7 mbq aktiv substans - krom(cr-51)edetat

فنلندا - السويدية - Ecolab

ecolab deutschland gmbh -

السويد - السويدية - Läkemedelsverket (Medical Products Agency)

orifarm generics a/s - ibuprofen; pseudoefedrinhydroklorid - filmdragerad tablett - 200 mg/30 mg - pseudoefedrinhydroklorid 30 mg aktiv substans; ibuprofen 200 mg aktiv substans

السويد - السويدية - Läkemedelsverket (Medical Products Agency)

teva sweden ab - oxikodonhydroklorid - depottablett - 5 mg - laktosmonohydrat hjälpämne; oxikodonhydroklorid 5 mg aktiv substans

السويد - السويدية - Läkemedelsverket (Medical Products Agency)

teva sweden ab - oxikodonhydroklorid - depottablett - 20 mg - laktosmonohydrat hjälpämne; oxikodonhydroklorid 20 mg aktiv substans

السويد - السويدية - Läkemedelsverket (Medical Products Agency)

teva sweden ab - oxikodonhydroklorid - depottablett - 40 mg - oxikodonhydroklorid 40 mg aktiv substans; laktosmonohydrat hjälpämne

السويد - السويدية - Läkemedelsverket (Medical Products Agency)

teva sweden ab - oxikodonhydroklorid - depottablett - 15 mg - oxikodonhydroklorid 15 mg aktiv substans; laktosmonohydrat hjälpämne

السويد - السويدية - Läkemedelsverket (Medical Products Agency)

teva sweden ab - oxikodonhydroklorid - depottablett - 10 mg - polysorbat 80 hjälpämne; laktosmonohydrat hjälpämne; oxikodonhydroklorid 10 mg aktiv substans

السويد - السويدية - Läkemedelsverket (Medical Products Agency)

teva sweden ab - oxikodonhydroklorid - depottablett - 30 mg - oxikodonhydroklorid 30 mg aktiv substans; laktosmonohydrat hjälpämne